Cara Therapeutics
CARA
#10717
Rank
ยฃ6.12 M
Marketcap
ยฃ4.02
Share price
-2.56%
Change (1 day)
22.72%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): -ยฃ16.45

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ15.86. In 2023 the company made an earnings per share (EPS) of -ยฃ19.75 a decrease over its 2022 EPS that were of -ยฃ14.41.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-ยฃ16.45-16.73%
2023-ยฃ19.7537.11%
2022-ยฃ14.41-8.09%
2021-ยฃ15.68
2019-ยฃ22.5620.87%
2018-ยฃ18.677.85%
2017-ยฃ17.31-9.05%
2016-ยฃ19.03110%
2015-ยฃ9.0617.65%
2014-ยฃ7.70-3.42%
2013-ยฃ7.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.60-141.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.99-106.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-ยฃ26.23 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ37.99 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-ยฃ1.68-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA